2-236166184-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The ENST00000306318.5(GBX2):c.777G>A(p.Leu259=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00412 in 1,613,972 control chromosomes in the GnomAD database, including 270 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.021 ( 122 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 148 hom. )
Consequence
GBX2
ENST00000306318.5 synonymous
ENST00000306318.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.236
Genes affected
GBX2 (HGNC:4186): (gastrulation brain homeobox 2) Enables sequence-specific double-stranded DNA binding activity. Predicted to be involved in regulation of nervous system development and regulation of transcription by RNA polymerase II. Predicted to act upstream of or within several processes, including branching involved in blood vessel morphogenesis; nervous system development; and neural crest cell migration. Predicted to be part of chromatin. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 2-236166184-C-T is Benign according to our data. Variant chr2-236166184-C-T is described in ClinVar as [Benign]. Clinvar id is 780367.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.236 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0724 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GBX2 | NM_001485.4 | c.777G>A | p.Leu259= | synonymous_variant | 2/2 | ENST00000306318.5 | NP_001476.2 | |
GBX2 | XM_047443907.1 | c.777G>A | p.Leu259= | synonymous_variant | 2/4 | XP_047299863.1 | ||
GBX2 | NM_001301687.2 | c.*145G>A | 3_prime_UTR_variant | 3/3 | NP_001288616.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GBX2 | ENST00000306318.5 | c.777G>A | p.Leu259= | synonymous_variant | 2/2 | 1 | NM_001485.4 | ENSP00000302251 | P1 | |
GBX2 | ENST00000551105.1 | c.*145G>A | 3_prime_UTR_variant | 3/3 | 1 | ENSP00000448747 | ||||
GBX2 | ENST00000465889.1 | n.446G>A | non_coding_transcript_exon_variant | 2/2 | 1 |
Frequencies
GnomAD3 genomes AF: 0.0214 AC: 3258AN: 152224Hom.: 123 Cov.: 33
GnomAD3 genomes
AF:
AC:
3258
AN:
152224
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00552 AC: 1383AN: 250752Hom.: 50 AF XY: 0.00410 AC XY: 557AN XY: 135720
GnomAD3 exomes
AF:
AC:
1383
AN:
250752
Hom.:
AF XY:
AC XY:
557
AN XY:
135720
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00232 AC: 3390AN: 1461630Hom.: 148 Cov.: 32 AF XY: 0.00200 AC XY: 1451AN XY: 727136
GnomAD4 exome
AF:
AC:
3390
AN:
1461630
Hom.:
Cov.:
32
AF XY:
AC XY:
1451
AN XY:
727136
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0214 AC: 3259AN: 152342Hom.: 122 Cov.: 33 AF XY: 0.0206 AC XY: 1534AN XY: 74504
GnomAD4 genome
AF:
AC:
3259
AN:
152342
Hom.:
Cov.:
33
AF XY:
AC XY:
1534
AN XY:
74504
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 23, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at